المؤلفون: Raoul JL; Department of Clinical Research, Institut de Cancérologie de l'Ouest, Saint-Herblain, France. Electronic address: jean-luc.raoul@ico.unicancer.fr., Hansten PD; School of Pharmacy, University of Washington, Seattle, USA. Electronic address: hansten@uw.edu.

المصدر: Cancer treatment reviews [Cancer Treat Rev] 2024 Sep; Vol. 129, pp. 102794. Date of Electronic Publication: 2024 Jul 01.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7502030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1967 (Electronic) Linking ISSN: 03057372 NLM ISO Abbreviation: Cancer Treat Rev Subsets: MEDLINE

مواضيع طبية MeSH: Proton Pump Inhibitors*/administration & dosage , Proton Pump Inhibitors*/therapeutic use , Neoplasms*/drug therapy, Humans ; Protein Kinase Inhibitors/therapeutic use ; Drug Interactions ; Immune Checkpoint Inhibitors/therapeutic use ; Antineoplastic Agents/therapeutic use

المؤلفون: Troise D; Nephrology, Dialysis and Transplantation Unit, Advanced Research Center on Kidney Aging (A.R.K.A.), Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy.; Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, 14152 Stockholm, Sweden., Mercuri S; Nephrology, Dialysis and Transplantation Unit, Advanced Research Center on Kidney Aging (A.R.K.A.), Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy., Infante B; Nephrology, Dialysis and Transplantation Unit, Advanced Research Center on Kidney Aging (A.R.K.A.), Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy., Losappio V; Nephrology, Dialysis and Transplantation Unit, Advanced Research Center on Kidney Aging (A.R.K.A.), Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy., Cirolla L; Nephrology, Dialysis and Transplantation Unit, Advanced Research Center on Kidney Aging (A.R.K.A.), Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy., Netti GS; Unit of Clinical Pathology, Advanced Research Center on Kidney Aging (A.R.K.A.), Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy., Ranieri E; Unit of Clinical Pathology, Advanced Research Center on Kidney Aging (A.R.K.A.), Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy., Stallone G; Nephrology, Dialysis and Transplantation Unit, Advanced Research Center on Kidney Aging (A.R.K.A.), Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy.

المصدر: International journal of molecular sciences [Int J Mol Sci] 2024 Aug 08; Vol. 25 (16). Date of Electronic Publication: 2024 Aug 08.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Sodium-Glucose Transporter 2 Inhibitors*/pharmacology , TOR Serine-Threonine Kinases*/metabolism , TOR Serine-Threonine Kinases*/antagonists & inhibitors , Aging*/drug effects , Aging*/metabolism , Drug Synergism*, Humans ; Animals ; MTOR Inhibitors/pharmacology ; MTOR Inhibitors/therapeutic use ; Cellular Senescence/drug effects

المؤلفون: Fumarola C; Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy., La Monica S; Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy., Bonelli M; Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy. Electronic address: mara.bonelli@unipr.it., Zoppi S; Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy., Alfieri R; Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy., Galetti M; Department of Occupational and Environmental Medicine, Epidemiology and Hygiene, INAIL-Italian Workers' Compensation Authority, Monte Porzio Catone, 00078 Rome, Italy., Gnetti L; Pathology Unit, University Hospital of Parma, 43126 Parma, Italy., Campanini N; Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy., Pozzi G; Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy., Cavazzoni A; Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy., Mazzaschi G; Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy., Silini EM; Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy., Buti S; Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy., Petronini PG; Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy.

المصدر: Biochemical pharmacology [Biochem Pharmacol] 2024 Aug; Vol. 226, pp. 116397. Date of Electronic Publication: 2024 Jun 27.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Science Country of Publication: England NLM ID: 0101032 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2968 (Electronic) Linking ISSN: 00062952 NLM ISO Abbreviation: Biochem Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Renal Cell*/drug therapy , Carcinoma, Renal Cell*/pathology , Kidney Neoplasms*/drug therapy , Kidney Neoplasms*/pathology , Angiogenesis Inhibitors*/pharmacology , Angiogenesis Inhibitors*/therapeutic use , Angiogenesis Inhibitors*/administration & dosage , Protein Kinase Inhibitors*/pharmacology , Protein Kinase Inhibitors*/therapeutic use , Sunitinib*/pharmacology , Sunitinib*/therapeutic use , Pyrimidines*/pharmacology , Pyrimidines*/therapeutic use , Sulfonamides*/pharmacology , Sulfonamides*/therapeutic use , Programmed Cell Death 1 Receptor*/antagonists & inhibitors , Programmed Cell Death 1 Receptor*/metabolism, Animals ; Humans ; Mice ; Cell Line, Tumor ; Indazoles/pharmacology ; Indazoles/therapeutic use ; Indazoles/administration & dosage ; Immune Checkpoint Inhibitors/pharmacology ; Immune Checkpoint Inhibitors/therapeutic use ; Female ; Xenograft Model Antitumor Assays/methods ; Nivolumab/pharmacology ; Nivolumab/therapeutic use ; Nivolumab/administration & dosage ; B7-H1 Antigen/antagonists & inhibitors ; B7-H1 Antigen/metabolism ; Tyrosine Kinase Inhibitors

المؤلفون: Chaaban I; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Alexandria University, Alexandria, 21521, Egypt., Hafez H; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Alexandria University, Alexandria, 21521, Egypt., Hazzaa A; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Alexandria University, Alexandria, 21521, Egypt., Domiati S; Department of Pharmacology and Therapeutics, Faculty of Pharmacy, Beirut Arab University, Tarik El Jadida, Riad El Solh, Beirut Campus, P.o box 11-5020, Beirut, 11072809, Lebanon. t.domyati@bau.edu.lb., Abd El Galil KH; Department of Pharmaceutical Sciences, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon.; Department of Microbiology and Immunology, Faculty of Pharmacy, Mansoura University, Alexandria, Egypt., Hdeib F; Department of Biomedical Science, School of Pharmacy, Lebanese International University, Beirut, Lebanon., Belal ASF; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Alexandria University, Alexandria, 21521, Egypt., Ragab H; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Alexandria University, Alexandria, 21521, Egypt.

المصدر: Inflammopharmacology [Inflammopharmacology] 2024 Aug; Vol. 32 (4), pp. 2395-2411. Date of Electronic Publication: 2024 Jun 10.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Birkhäuser Country of Publication: Switzerland NLM ID: 9112626 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1568-5608 (Electronic) Linking ISSN: 09254692 NLM ISO Abbreviation: Inflammopharmacology Subsets: MEDLINE

مواضيع طبية MeSH: Lipoxygenase Inhibitors*/pharmacology , Cyclooxygenase 2*/metabolism , Edema*/drug therapy , Quinones*/pharmacology , Anti-Inflammatory Agents*/pharmacology, Animals ; Rats ; Male ; Cyclooxygenase Inhibitors/pharmacology ; Structure-Activity Relationship ; Molecular Docking Simulation/methods ; Arachidonate 5-Lipoxygenase/metabolism ; Rats, Wistar ; Cyclooxygenase 1/metabolism ; Cyclooxygenase 2 Inhibitors/pharmacology ; Carrageenan

المؤلفون: Kumar N; Laboratory of Organic and Medicinal Chemistry, Department of Chemistry, Central University of Punjab, Bathinda, Punjab 151401, India., Jangid K; Laboratory of Organic and Medicinal Chemistry, Department of Chemistry, Central University of Punjab, Bathinda, Punjab 151401, India.; Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Bathinda, Punjab 151401, India., Kumar V; Department of Pharmacology, Central University of Punjab, Bathinda, Punjab 151401, India., Yadav RP; Gastrointestinal Disease Lab, Department of Microbiology, Central University of Punjab, Bathinda, Punjab 151401, India., Mishra J; Laboratory of Translational Medicine and Nanotherapeutics, Department of Human Genetics and Molecular Medicine, Central University of Punjab, Bathinda, Punjab 151401, India., Upadhayay S; Department of Pharmacology, Central University of Punjab, Bathinda, Punjab 151401, India., Kumar V; Laboratory of Organic and Medicinal Chemistry, Department of Chemistry, Central University of Punjab, Bathinda, Punjab 151401, India., Devi B; Laboratory of Organic and Medicinal Chemistry, Department of Chemistry, Central University of Punjab, Bathinda, Punjab 151401, India., Kumar V; Laboratory of Organic and Medicinal Chemistry, Department of Chemistry, Central University of Punjab, Bathinda, Punjab 151401, India., Dwivedi AR; Department of Pharmaceutical Sciences and Natural Products, Central University of Punjab, Bathinda, Punjab 151401, India.; Gitam School of Pharmacy, Hyderabad, Telangana 502329, India., Kumar P; Department of Pharmacology, Central University of Punjab, Bathinda, Punjab 151401, India., Baranwal S; Gastrointestinal Disease Lab, Department of Microbiology, Central University of Punjab, Bathinda, Punjab 151401, India., Bhatti JS; Laboratory of Translational Medicine and Nanotherapeutics, Department of Human Genetics and Molecular Medicine, Central University of Punjab, Bathinda, Punjab 151401, India., Kumar V; Laboratory of Organic and Medicinal Chemistry, Department of Chemistry, Central University of Punjab, Bathinda, Punjab 151401, India.

المصدر: ACS chemical neuroscience [ACS Chem Neurosci] 2024 Jul 17; Vol. 15 (14), pp. 2565-2585. Date of Electronic Publication: 2024 May 25.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101525337 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1948-7193 (Electronic) Linking ISSN: 19487193 NLM ISO Abbreviation: ACS Chem Neurosci Subsets: MEDLINE

مواضيع طبية MeSH: Zebrafish* , Scopolamine*/pharmacology , Chromones*/pharmacology , Cholinesterase Inhibitors*/pharmacology , Cholinesterase Inhibitors*/chemical synthesis , Alzheimer Disease*/drug therapy , Alzheimer Disease*/metabolism, Animals ; Humans ; Neuroprotective Agents/pharmacology ; Amyloid beta-Peptides/metabolism ; Disease Models, Animal ; Acetylcholinesterase/metabolism ; Ligands ; Monoamine Oxidase/metabolism ; Cell Line, Tumor ; Reactive Oxygen Species/metabolism ; Monoamine Oxidase Inhibitors/pharmacology ; Monoamine Oxidase Inhibitors/chemistry

المؤلفون: Khamees Thabet H; Department of Chemistry, College of Sciences and Arts, Northern Border University, Rafha, 91911, Saudi Arabia., Ragab A; Department of Chemistry, Faculty of Science (Boys), Al-Azhar University, Nasr City, 11884, Cairo, Egypt. Electronic address: ahmed_ragab7@ymail.com., Imran M; Department of Pharmaceutical Chemistry, College of Pharmacy, Northern Border University, Rafha, 91911, Saudi Arabia., Helal MH; Department of Chemistry, College of Sciences and Arts, Northern Border University, Rafha, 91911, Saudi Arabia., Ibrahim Alaqel S; Department of Pharmaceutical Chemistry, College of Pharmacy, Northern Border University, Rafha, 91911, Saudi Arabia., Alshehri A; Department of Pharmacology and Toxicology, College of Pharmacy, Northern Border University, Rafha, 91911, Saudi Arabia; Department of Pharmacology, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, King Faisal Road, Dammam, 31441, Saudi Arabia., Ash Mohd A; Department of Pharmaceutical Chemistry, College of Pharmacy, Northern Border University, Rafha, 91911, Saudi Arabia., Rakan Alshammari M; Department of Chemistry, College of Sciences and Arts, Northern Border University, Rafha, 91911, Saudi Arabia., S Abusaif M; Department of Chemistry, Faculty of Science (Boys), Al-Azhar University, Nasr City, 11884, Cairo, Egypt., A Ammar Y; Department of Chemistry, Faculty of Science (Boys), Al-Azhar University, Nasr City, 11884, Cairo, Egypt.

المصدر: European journal of medicinal chemistry [Eur J Med Chem] 2024 Sep 05; Vol. 275, pp. 116589. Date of Electronic Publication: 2024 Jun 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1768-3254 (Electronic) Linking ISSN: 02235234 NLM ISO Abbreviation: Eur J Med Chem Subsets: MEDLINE

مواضيع طبية MeSH: alpha-Amylases*/antagonists & inhibitors , alpha-Amylases*/metabolism , Molecular Docking Simulation* , Glycoside Hydrolase Inhibitors*/pharmacology , Glycoside Hydrolase Inhibitors*/chemical synthesis , Glycoside Hydrolase Inhibitors*/chemistry , alpha-Glucosidases*/metabolism , Hypoglycemic Agents*/pharmacology , Hypoglycemic Agents*/chemistry , Hypoglycemic Agents*/chemical synthesis , Acetaminophen*/pharmacology , Drug Design*, Structure-Activity Relationship ; Molecular Structure ; Humans ; Dose-Response Relationship, Drug ; Sulfonamides/chemistry ; Sulfonamides/pharmacology ; Sulfonamides/chemical synthesis ; Drug Discovery ; Enzyme Inhibitors/pharmacology ; Enzyme Inhibitors/chemistry ; Enzyme Inhibitors/chemical synthesis

المؤلفون: Chen J; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Collaborative Innovation Center of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China., Liu S; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Collaborative Innovation Center of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China., Ruan Z; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Collaborative Innovation Center of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China., Wang K; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China; Sino-French Research Center for Life Sciences and Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China. Electronic address: kankanwang@shsmu.edu.cn., Xi X; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Collaborative Innovation Center of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China. Electronic address: xixiaodong@shsmu.edu.cn., Mao J; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Collaborative Innovation Center of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China. Electronic address: jianhuamao@shsmu.edu.cn.

المصدر: Blood reviews [Blood Rev] 2024 Sep; Vol. 67, pp. 101220. Date of Electronic Publication: 2024 Jun 07.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 8708558 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1681 (Electronic) Linking ISSN: 0268960X NLM ISO Abbreviation: Blood Rev Subsets: MEDLINE

مواضيع طبية MeSH: Thrombosis*/etiology , Thrombosis*/prevention & control , Hemorrhage*/etiology , Hemorrhage*/prevention & control , Hemorrhage*/chemically induced , Immune Checkpoint Inhibitors*/adverse effects , Immune Checkpoint Inhibitors*/therapeutic use , Fibrinolytic Agents*/therapeutic use , Fibrinolytic Agents*/adverse effects , Neoplasms*/drug therapy , Neoplasms*/complications, Humans ; Platelet Aggregation Inhibitors/therapeutic use ; Platelet Aggregation Inhibitors/adverse effects ; Animals

المؤلفون: Sarma S; Institute of Health Policy, Management and Evaluation, University of Toronto, Ontario, Canada; Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center, Boston, MA, United States of America., Hodzic-Santor B; Division of General Internal Medicine, Sinai Health System, Toronto, Ontario, Canada., Raissi A; Division of General Internal Medicine, Sinai Health System, Toronto, Ontario, Canada., Colacci M; Institute of Health Policy, Management and Evaluation, University of Toronto, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Verma AA; Institute of Health Policy, Management and Evaluation, University of Toronto, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of General Internal Medicine, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada., Razak F; Institute of Health Policy, Management and Evaluation, University of Toronto, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of General Internal Medicine, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada., Højbjerg Lassen MC; Department of Cardiology, Gentofte University Hospital, University of Copenhagen, Copenhagen, Denmark., Fralick M; Institute of Health Policy, Management and Evaluation, University of Toronto, Ontario, Canada; Division of General Internal Medicine, Sinai Health System, Toronto, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, Canada. Electronic address: mike.fralick@utoronto.ca.

المصدر: Journal of diabetes and its complications [J Diabetes Complications] 2024 Sep; Vol. 38 (9), pp. 108827. Date of Electronic Publication: 2024 Jul 29.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Elsevier Science Pub. Co Country of Publication: United States NLM ID: 9204583 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-460X (Electronic) Linking ISSN: 10568727 NLM ISO Abbreviation: J Diabetes Complications Subsets: MEDLINE

مواضيع طبية MeSH: Diabetic Ketoacidosis*/epidemiology , Diabetic Ketoacidosis*/chemically induced , Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use , Sodium-Glucose Transporter 2 Inhibitors*/adverse effects , Hospitalization*/statistics & numerical data , Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/complications , Diabetes Mellitus, Type 2*/blood , Diabetes Mellitus, Type 2*/epidemiology, Humans ; Male ; Female ; Middle Aged ; Cohort Studies ; Aged ; Adult ; Dipeptidyl-Peptidase IV Inhibitors/therapeutic use ; Dipeptidyl-Peptidase IV Inhibitors/adverse effects ; Risk Factors ; Hypoglycemic Agents/adverse effects ; Hypoglycemic Agents/therapeutic use

المؤلفون: Rothschild AJ; Department of Psychiatry, University of Massachusetts Chan Medical School UMass Memorial HealthCare, Worcester, MA. anthony.rothschild@umassmemorial.org.

المصدر: Journal of clinical psychopharmacology [J Clin Psychopharmacol] 2024 Sep-Oct 01; Vol. 44 (5), pp. 531-532. Date of Electronic Publication: 2024 Aug 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Williams And Wilkins Country of Publication: United States NLM ID: 8109496 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-712X (Electronic) Linking ISSN: 02710749 NLM ISO Abbreviation: J Clin Psychopharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Depressive Disorder, Major*/drug therapy , Selective Serotonin Reuptake Inhibitors*/adverse effects , Serotonin and Noradrenaline Reuptake Inhibitors*/adverse effects , Serotonin and Noradrenaline Reuptake Inhibitors*/pharmacology, Humans ; Drug Substitution ; Antidepressive Agents/adverse effects ; Adrenergic Uptake Inhibitors/adverse effects ; Adrenergic Uptake Inhibitors/therapeutic use ; Adrenergic Uptake Inhibitors/administration & dosage

المؤلفون: Yu J; Division of Hematology and Medical Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA., Park R; Division of Hematology and Medical Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA., Tojjari A; Department of Medicine, Division of Hematology and Oncology, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA., Sadeghipour A; Department of Biochemistry, Faculty of Biological Sciences, Tarbiat Modarres University, Tehran, Iran., Saeed A; Department of Medicine, Ochsner Lafayette General Medical Center, Lafayette, LA, USA., Saeed A; Department of Medicine, Division of Hematology and Oncology, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.

المصدر: Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2024 Sep; Vol. 33 (9), pp. 887-895. Date of Electronic Publication: 2024 Aug 07.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9434197 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7658 (Electronic) Linking ISSN: 13543784 NLM ISO Abbreviation: Expert Opin Investig Drugs Subsets: MEDLINE

مواضيع طبية MeSH: Protein Kinase Inhibitors*/pharmacology , Protein Kinase Inhibitors*/adverse effects , Protein Kinase Inhibitors*/administration & dosage , Neoplasms*/drug therapy, Humans ; Animals ; Immune Checkpoint Inhibitors/adverse effects ; Immune Checkpoint Inhibitors/pharmacology ; Immune Checkpoint Inhibitors/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/adverse effects ; Antineoplastic Agents/administration & dosage ; Pyrazoles/pharmacology ; Pyrazoles/adverse effects ; Pyrazoles/administration & dosage ; Drug Synergism ; Tyrosine Kinase Inhibitors ; Benzofurans ; Quinazolines